GreenLight Biosciences, Samsung Biologics collaborate on COVID-19 mRNA vaccine manufacturing

By The Science Advisory Board staff writers

November 24, 2021 -- Samsung Biologics will collaborate with GreenLight Biologics to manufacture an mRNA COVID-19 vaccine candidate at a commercial scale. The partnership aims to accelerate production of GreenLight's COVID-19 vaccine candidate for phase III clinical trials, subject to regulatory approval.

The collaboration with Samsung will leverage GreenLight's existing manufacturing process, and technology transfer to Samsung will begin immediately, according to both firms.

GreenLight Biosciences is a biotechnology company that was founded in 2008; it is dedicated to making RNA products affordable and accessible. In August 2021, GreenLight announced plans to become publicly listed through a business combination with Environmental Impact Acquisition Corp.

Samsung Biologics is a contract manufacturing organization that provides integrated end-to-end contract development and manufacturing services.


Copyright © 2021 scienceboard.net
 
To access all The ScienceBoard content create a free account now:


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.


Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here